BNET Industries
Last Fiscal Year Sales:$35.9B
- Public
- DE
Dow Jones Description
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and improved earning power. We already successfully reorganized the Bayer Group and further streamlined our portfolio to create a new Bayer that is focused on its corporate strengths, its customers and the markets of the future. To help us achieve this goal, we then carried out a strategic realignment in order to concentrate in future on three high-potential, agile subgroups with largely independent operations: HealthCare, CropScience and MaterialScience, supported by three service companies. Our operating companies give us the access we need to the growth markets of the future. As an inventor company, we plan to continue setting trends in research-intensive areas. Innovations are the foundation for our competitiveness and our corporate growth, and thus for our success in the future. We believe our technical and commercial expertise entails a duty to contribute to sustainable development ? a principle we wholeheartedly endorse, mindful of its social, ethical and environmental elements. In awareness of our responsibilities as a corporate citizen, we define economy, ecology and social commitment as objectives of equal rank. We seek to retain society?s confidence through performance, flexibility and open communication as we work in pursuit of our overriding corporate goals: to steadily create corporate value and generate high value-added for the benefit of our stockholders, our employees and the community in every country in which we operate.
Director, Finance
Klaus KuhnNumber of Employees 122,100
Peer Companies
NAICS Code Plastics Material and Resin Manufacturing: 325211
Recent Events
-
Bayer and United Nations Environment Programme Launch 19th Annual International Children's...
-
Bayer Consumer Care Launches CitracalR Calcium Plus Heart Health
-
German drug, chemical company Bayer's Q3 net income falls 10 per cent
-
Bayer, US Onyx launch phase III trial of Nexavar in patients with non-responsive thyroid cancer
-
BRIEF-Credit Suisse raises targets on European pharma cos
-
Bayer accused of hiding Yaz contraceptive risk
-
Bayer downgraded to neutral from buy at UBS
-
Abbott Laboratories to acquire Solvay Pharmaceuticals
-
Bayer's contested kidney cancer drug shows benefit
-
Bayer names new CEO
-
Bayer Introduces CONTOUR USB - The First Blood Glucose Meter With Unique Plug & Play...
-
Bayer's next CEO has a year to prepare Today
-
Bayer AG tabs outsider as CEO's successor
-
Bayer Unveils Management Shuffle
News & Analysis
Filter by
bayer ag and manufacturing - All News and Analysis
Doc Indicted for Prescribing Bayer's Cheap Canadian Mirena Instead of Expensive U.S. Mirena
BNET
- 2009-10-13
An Arkansas doctor has been indicted for prescribing a Bayer IUD obtained from a Canadian pharmacy instead of the more expensive version available in the U.S. Dr. Kelly Dean Shrum, 41, was charged with one count of misbranding in violation of the Food, Drug, & Cosmetic Act, one count of...
Bayer Loses Nexavar Case in India; Could Open Door to Easier Generic Approvals
BNET
- 2009-08-20
Bayer has lost an attempt in the high court in Delhi to link new drug approvals to the validity of patent exclusivity. Depending on your point of view, the ruling either potentially opens the door for Indian generic manufacturers like Cipla, Dr Reddy's and Ranbaxy to decimate the branded drug...
Bayer Funding of Beekeepers' Association Draws Controversy
BNET
- 2009-01-19
Bayer's role (or lack thereof -- the science jury is still out) in the mass death of bees just keeps making news. The annual meeting of the British Beekeepers Association became contentious over a vote on whether the BBKA should endorse certain pesticides. The BBKA executive panel won the vote...
Bayer CropScience, has received registration from the EPA for its TRILEX Advanced Seed-Applied System
- 2007-01-01
Bayer CropScience, has received registration from the EPA for its TRILEX Advanced Seed-Applied System for controlling key cotton seedling diseases. Also at Bayer, USDA formally approves a strain of genetically engineered rice whose discovery in commercial stocks earlier this year triggered a food market dispute with the European Union...
European groups demand ban on US rice
- 2006-11-01
Environmental and food-safety groups have called for the biotech industry to be held to greater account if further contamination of the food chain with genetically modified foodstuffs is not to occur.The calls came after a strain of GM rice produced by biotech food giant, Bayer Crop Science, found its way...
Kimball Electronics Acquires Bayer Healthcare Manufacturing Operation; Wales, U.K. Facility Supports Growth and Diversification
- 2006-04-03
JASPER, Ind. -- Kimball Electronics Group, Inc., through its related subsidiaries, has announced the acquisition of the manufacturing operation for Bayer HealthCare's Diagnostics Division located in Bridgend, Wales, UK. Bayer HealthCare's Diagnostics Division operates as part of Bayer Healthcare LLC, a member of the worldwide Bayer Group (NYSE:BAY). Kimball purchased...
Price fixing rebounds on rubber cartel.(COMPANY NEWS)
- 2006-02-01
The European Commission EC has imposed fines totalling 75.86 million [euro] on four rubber chemicals manufacturers for running a cartel. The four companies are Bayer, Crompton now Chemtura, General Chimica and Flexsys. Although the EC proved that the companies were involved in price-fixing...
URGENT ACTION MUST BE TAKEN TO BOOST RICE PRODUCTION, SAY EXPERTS.
- 2004-12-21
Growth in rice yields is falling behind population growth and urgent action must be taken to reverse this, development experts said on December 8. Representatives from the UN's Food and Agriculture Organisation FAO and the European Parliament spoke at an event on rice organised by CropLife...
Bayer US unit to pay 33 million dollar fine in price-fixing probe
- 2004-09-30
WASHINGTON AFP — The US division of Germany's Bayer AG agreed to pay a 33 million dollar fine to settle charges it participated in a conspiracy to fix prices of a commonly used chemical for plastics and other goods, US officials said. The Justice Department said that in the...
Bayer CropScience bins plans to market GM maize in Britain
- 2004-03-31
MONHEIM, Germany AFP ? Bayer CropScience, the agrochemicals arm of German pharmaceuticals and chemicals giant Bayer, said it has decided to abandon plans to market genetically modified GM crops in Britain following a recent policy announcement by the British government. "Bayer CropScience has decided to discontinue further efforts to...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Klaus Kuhn | Director, Finance |
| Richard Pott | Director, Strategy and Human Resources |
| Wolfgang Plischke | Director, Innovation, Technology and Environment |
| Hartmut Klusik | Head, Product Supply |
| Gary S Balkema | Executive Committee Member |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Arthur J Higgins | Chairman, HealthCare |
| Werner Wenning | Executive Chairman |
| Klaus Kleinfeld | Board of Directors |
| Paul Achleitner | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Finance | Current |
| University of South Carolina | MBA | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Strategy and Human Resources | Current |
| University of Cologne | doctorate in physics | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Innovation, Technology and Environment | Current |
| Bayer HealthCare AG | Manager | Current |
| Bayer HealthCare AG | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Head, Product Supply | Current |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Chairman, HealthCare | Current |
| Enzon Pharmaceuticals, Inc. | CEO | Former |
| Pharmaceutical Research and Manufacturers of America | member | Former |
| Bayer HealthCare, Animal Health Division | Chairman | Former |
| Enzon Pharmaceuticals, Inc. | Chairman | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Executive Chairman | Current |
| Henkel AG & Co. KGaA | Supervisory Board | Current |
Klaus Kleinfeld is president and chief executive officer of Alcoa. He joined the company in 2007 as president and chief operating officer and seven months later assumed CEO responsibilities. He has served on Alcoa's board of directors since 2003. Alcoa is a world leader in the production and management of a very sustainable product: aluminum. Nearly 75% of the aluminum ever produced since 1888 is still in use today. The company has been a technology leader since its beginning, providing more than 90% of the aluminum alloys used in aircraft and space flight; helping making automobiles lighter, without compromising safety or performance; manufacturing sheet that created the ultimate recyclable container, the aluminum beverage can; and providing building and construction industry materials that help further the green building movement. In addition, to serving customers in these markets, Alcoa also markets wheels, fastening systems, precision and investment castings, and building systems. The company has 97,000 employees in 34 countries. Before coming to Alcoa, Mr. Kleinfeld had a 20-year career with Siemens, the global electronics and industrial conglomerate, based in the U.S. and Germany, where he served as chief executive officer of Siemens AG starting in 2005. During his tenure, Mr. Kleinfeld presided over a dramatic transformation of the company, reshaping the company's portfolio around three high growth areas, resulting in increase of revenues and market capitalization nearly doubled. Prior to his service on the Managing Board of Siemens AG, Mr. Kleinfeld was President and Chief Executive Officer of Siemens Corporation, its U.S. arm and the company's largest region. In addition to serving on Alcoa's board, he is a member of the board of Bayer AG. On the personal front, Mr. Kleinfeld was born in Bremen, Germany and educated at the University of Goettingen and University of Wuerzburg, both in Germany. He holds a Ph.D in strategic management and master's degree in business administration. In his leisure time, he enjoys skiing, tennis, the arts and is a marathon runner. Mr. Kleinfeld resides in New York with his wife and children.
| Organization | Position | Status |
|---|---|---|
| Alcoa, Inc. | President & Chief Executive Officer | Current |
| Bayer AG | Board of Directors | Current |
| Alcoa, Inc. | Board of Directors | Current |
| Siemens AG | President & CEO | Former |
| Siemens Corporation | Chief Executive Officer | Former |
| Alcoa, Inc. | Chief Operating Officer | Former |
| Siemens Corporation | Chief Operating Officer | Former |
| Siemens AG | Chief Operations Officer, U.S. | Former |
| Siemens AG | Executive Vice President | Former |
| Siemens AG | Audit Committee Principal | Former |
| Citigroup Inc. | Board of Directors | Former |
| Siemens AG | Board of Directors | Former |
| Siemens Corporation | member | Former |
| Organization | Position | Status |
|---|---|---|
| Allianz SE | Executive Director, Finance | Current |
| Bayer AG | Board of Directors | Current |
| Goldman, Sachs & Co. | Vice President, Mergers & Acquisitions | Former |
| Bain & Company | Manager, Strategy Consulting | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Executive Committee Member | Current |
| Bayer HealthCare, Animal Health Division | President, Worldwide Bayer Consumer Care Division | Former |
| Fairleigh Dickinson University | master of business administration degree | Former |
Executive News
-
Report from Europe: U.S. Close vs. China Rebound
-
Alcoa Named Component of Dow Jones Sustainability Index for Eighth Consecutive Year
-
Alcoa says global aluminium demand to fall 5.5 pct -Bloomberg
-
Siemens To Settle Bribery Charges with Three Former Execs
-
Siemens poised to settle with ex-managers
-
UPDATE 1-Siemens poised to settle with ex-managers
-
UPDATE 1-Siemens poised to settle with ex-managers
-
Bayer AG (BAY.F) May Be Ready for Deals After Lost Intervet Bid
-
Inventories May Temper Aluminum Rally
Industry Transcripts by Seeking Alpha
-
Deere & Company F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Nov 25, 2009about DE
-
Brown Shoe Co. Inc. Q3 2009 Earnings Call Transcript
on Nov 24, 2009about BWS
-
Daktronics Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about DAKT
-
Haynes International Inc. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Nov 24, 2009about HAYN
-
Valspar Corp. F4Q09 (Qtr End 30/10/09) Earnings Call Transcript
on Nov 23, 2009about VAL
Glass Door
Bayer AG
IndustryTop Rated
